HIV protection with just two shots a year: FDA approves Gilead drug
A new twice-yearly shot could be a “game changer” in the fight against AIDS, but experts’ hopes have dimmed because of the current political climate.
Related Articles
PEPFAR keeps millions of people with HIV alive and may be spared from Trump spending cuts
The HIV/AIDS program known as PEPFAR has faced a severe threat as the Trump administration dismantles most foreign aid, but on Tuesday it appeared to be spared…
An unusual use for AI in medical education
In this edition of AI Prognosis: A look at AI in medical education, CASP getting caught up in NIH chaos, and trust in AI.
ViiV expands licensing deal for its HIV drug in low-income countries
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, reflecting ongoing pressure to respond to criticism.
Kennedy dismisses two top HHS aides
HHS hasn’t said why two top aides to RFK Jr. were dismissed this week.
25 years ago, I reported on horrifying hospital errors. Here’s what’s changed since then — and what hasn’t
Twenty-five years ago, Larry Tye reported on hospital errors for the Boston Globe. His recent wrist surgery showed just how much things have changed since…
Scientists show that mRNA therapy can be delivered as a capsule
Researchers used a capsule engineered to prevent stomach acids from degrading liquid mRNA therapy to treat inflammatory bowel disease.
Births of eight healthy children show promise of mitochondrial replacement therapy
A pioneering reproductive technology reduced the risk of children inheriting disease-causing mutations in mitochondria, researchers reported.
Scientists show that mRNA therapy can be delivered as a capsule
Researchers used a capsule engineered to prevent stomach acids from degrading liquid mRNA therapy to treat inflammatory bowel disease.
Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting move
Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following the deaths of two teenagers administered its…
CMS expands remote patient monitoring without heeding warnings about abuse
RPM companies see a win in Medicare’s plan to expand coverage, and the absence of any proposed guardrails.